Literature DB >> 21737902

Substance P and calcitonin gene related peptide mediate pain in chronic pancreatitis and their expression is driven by nerve growth factor.

LianSheng Liu1, Mohan Shenoy, Pankaj Jay Pasricha.   

Abstract

CONTEXT: Calcitonin gene-related peptide (CGRP), substance P and nerve growth factor play an important role in inflammatory pain in various somatic pain models but their role in chronic pancreatitis has not been well studied.
OBJECTIVES: The aim of this study was to investigate the effects of intrathecal administration of calcitonin gene-related peptide antagonist and substance P receptor antagonist on pain behavior in a rat model of chronic pancreatitis and to determine whether nerve growth factor drives the up-regulation of expression of these neuropeptides in sensory neurons.
METHODS: Pancreatitis was induced by retrograde infusion of trinitobenzene sulfonic acid into the pancreatic duct of adult rats. Three weeks post infusion continuous intrathecal infusion of the calcitonin gene-related peptide antagonist alpha CGRP8-37 or neurokinin-1 receptor antagonist CP-96345 or its inactive enantiomer CP-96344 was administered for seven days. The effects of treatment on pancreatic hyperalgesia were assessed by sensitivity of the abdominal wall to von Frey filament probing as well as by the nocifensive response to electrical stimulation of the pancreas. In a separate experiment chronic pancreatitis was induced and pancreas specific dorsal root ganglion neurons labeled with DiI were assessed for calcitonin gene-related peptide and substance P immunoreactivity.
RESULTS: Intrathecal infusion of calcitonin gene-related peptide and neurokinin-1 receptor antagonists significantly attenuated behavioral pain responses in rats with chronic pancreatitis. Further, treatment of chronic pancreatitis rats with nerve growth factor antibody significantly reduced pancreas specific neurons expressing calcitonin gene-related peptide and substance P in thoracic dorsal root ganglion.
CONCLUSIONS: Calcitonin gene-related peptide and substance P mediate pancreatic hyperalgesia in chronic pancreatitis and nerve growth factor in turn sustains the up-regulation of these neuropeptides in pancreatic sensory neurons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21737902      PMCID: PMC4090212     

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  24 in total

1.  The neurokinin-2 receptor is not involved in the sensitization of primary afferents of the rat knee joint.

Authors:  Matthias Pawlak; Robert F Schmidt; Christian Nitz; Ulrike Hanesch
Journal:  Neurosci Lett       Date:  2002-06-28       Impact factor: 3.046

2.  Nerve growth factor and its high-affinity receptor in chronic pancreatitis.

Authors:  H Friess; Z W Zhu; F F di Mola; C Kulli; H U Graber; A Andren-Sandberg; A Zimmermann; M Korc; M Reinshagen; M W Büchler
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

3.  Differential contribution of substance P and neurokinin A to spinal cord neurokinin-1 receptor signaling in the rat.

Authors:  J A Trafton; C Abbadie; A I Basbaum
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

4.  Nerve growth factor modulates TRPV1 expression and function and mediates pain in chronic pancreatitis.

Authors:  Yaohui Zhu; Tugba Colak; Mohan Shenoy; Liansheng Liu; Reetesh Pai; Cuiping Li; Kshama Mehta; Pankaj Jay Pasricha
Journal:  Gastroenterology       Date:  2011-04-05       Impact factor: 22.682

5.  Calcitonin gene-related peptide receptor activation produces PKA- and PKC-dependent mechanical hyperalgesia and central sensitization.

Authors:  Rui-Qing Sun; Yi-Jun Tu; Nada B Lawand; Jing-Yin Yan; Qing Lin; William D Willis
Journal:  J Neurophysiol       Date:  2004-11       Impact factor: 2.714

6.  Course and outcome of chronic pancreatitis. Longitudinal study of a mixed medical-surgical series of 245 patients.

Authors:  R W Ammann; A Akovbiantz; F Largiader; G Schueler
Journal:  Gastroenterology       Date:  1984-05       Impact factor: 22.682

7.  Changes in peptidergic innervation in chronic pancreatitis.

Authors:  M Büchler; E Weihe; H Friess; P Malfertheiner; E Bockman; S Müller; D Nohr; H G Beger
Journal:  Pancreas       Date:  1992       Impact factor: 3.327

8.  Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation.

Authors:  C J Woolf; Q P Ma; A Allchorne; S Poole
Journal:  J Neurosci       Date:  1996-04-15       Impact factor: 6.167

9.  Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity.

Authors:  C J Woolf; B Safieh-Garabedian; Q P Ma; P Crilly; J Winter
Journal:  Neuroscience       Date:  1994-09       Impact factor: 3.590

Review 10.  NGF as a mediator of inflammatory pain.

Authors:  S B McMahon
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1996-03-29       Impact factor: 6.237

View more
  13 in total

Review 1.  Unraveling the mystery of pain in chronic pancreatitis.

Authors:  Pankaj Jay Pasricha
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-01-24       Impact factor: 46.802

Review 2.  Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer.

Authors:  Jami L Saloman; Kathryn M Albers; Zobeida Cruz-Monserrate; Brian M Davis; Mouad Edderkaoui; Guido Eibl; Ariel Y Epouhe; Jeremy Y Gedeon; Fred S Gorelick; Paul J Grippo; Guy E Groblewski; Sohail Z Husain; Keane K Y Lai; Stephen J Pandol; Aliye Uc; Li Wen; David C Whitcomb
Journal:  Pancreas       Date:  2019-07       Impact factor: 3.327

3.  Mechanism, assessment and management of pain in chronic pancreatitis: Recommendations of a multidisciplinary study group.

Authors:  Michelle A Anderson; Venkata Akshintala; Kathryn M Albers; Stephen T Amann; Inna Belfer; Randall Brand; Suresh Chari; Greg Cote; Brian M Davis; Luca Frulloni; Andres Gelrud; Nalini Guda; Abhinav Humar; Rodger A Liddle; Adam Slivka; Rachelle Stopczynski Gupta; Eva Szigethy; Jyothsna Talluri; Wahid Wassef; C Mel Wilcox; John Windsor; Dhiraj Yadav; David C Whitcomb
Journal:  Pancreatology       Date:  2015-11-11       Impact factor: 3.996

4.  Neuronal Transforming Growth Factor beta Signaling via SMAD3 Contributes to Pain in Animal Models of Chronic Pancreatitis.

Authors:  Liansheng Liu; Yaohui Zhu; Michaël Noë; Qian Li; Pankaj Jay Pasricha
Journal:  Gastroenterology       Date:  2018-03-02       Impact factor: 22.682

Review 5.  Sensory nerves and pancreatitis.

Authors:  Qingfu Li; Jie Peng
Journal:  Gland Surg       Date:  2014-11

Review 6.  Control of arthritis pain with anti-nerve-growth factor: risk and benefit.

Authors:  Matthias F Seidel; Nancy E Lane
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

7.  Serum biomarkers for chronic pancreatitis pain patterns.

Authors:  Jami L Saloman; Gong Tang; Kimberly M Stello; Kristen E Hall; Xianling Wang; Samer AlKaade; Peter A Banks; Randall E Brand; Darwin L Conwell; Gregory A Coté; Christopher E Forsmark; Timothy B Gardner; Andres Gelrud; Michele D Lewis; Stuart Sherman; Adam Slivka; David C Whitcomb; Dhiraj Yadav
Journal:  Pancreatology       Date:  2021-09-30       Impact factor: 3.996

8.  Calcitonin gene-related peptide-expressing sensory neurons and spinal microglial reactivity contribute to pain states in collagen-induced arthritis.

Authors:  Francisco R Nieto; Anna K Clark; John Grist; Victoria Chapman; Marzia Malcangio
Journal:  Arthritis Rheumatol       Date:  2015-06       Impact factor: 10.995

9.  Antinociceptive effects of dexmedetomidine via spinal substance P and CGRP.

Authors:  Ruiqin Li; Feng Qi; Junlong Zhang; Yong Ji; Dengxin Zhang; Zhiyun Shen; Weifu Lei
Journal:  Transl Neurosci       Date:  2015-12-16       Impact factor: 1.757

10.  Compromised Neurotrophic and Angiogenic Regenerative Capability during Tendon Healing in a Rat Model of Type-II Diabetes.

Authors:  Aisha S Ahmed; Jian Li; Alim M D Abdul; Mahmood Ahmed; Claes-Göran Östenson; Paul T Salo; Carolyn Hewitt; David A Hart; Paul W Ackermann
Journal:  PLoS One       Date:  2017-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.